1. Home
  2. BFC vs NUVB Comparison

BFC vs NUVB Comparison

Compare BFC & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$139.91

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$5.17

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
NUVB
Founded
1894
2018
Country
United States
United States
Employees
N/A
298
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BFC
NUVB
Price
$139.91
$5.17
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$157.00
$11.38
AVG Volume (30 Days)
78.1K
3.8M
Earning Date
04-16-2026
05-04-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
N/A
EPS
1.78
N/A
Revenue
N/A
N/A
Revenue This Year
$58.67
$203.82
Revenue Next Year
$2.01
$58.18
P/E Ratio
$76.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$109.11
$1.57
52 Week High
$153.00
$9.75

Technical Indicators

Market Signals
Indicator
BFC
NUVB
Relative Strength Index (RSI) 46.14 65.42
Support Level $119.60 $5.22
Resistance Level $140.93 $5.55
Average True Range (ATR) 3.78 0.31
MACD -0.59 0.06
Stochastic Oscillator 44.14 99.62

Price Performance

Historical Comparison
BFC
NUVB

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: